KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

This advanced four-compound research vial combines GHK-Cu, KPV, BPC-157, and TB500, designed for researchers investigating synergistic pathways in regeneration, inflammation modulation, and peptide-driven recovery. Each component has been studied individually in preclinical models, and this blend provides a unified platform for examining tissue repair and cellular healing processes.

Blend Composition (Per Vial):
GHK-Cu – 50mg
KPV – 10mg
BPC-157 – 10mg
TB500 – 10mg

Key Characteristics:

• GHK-Cu: Copper peptide studied for collagen synthesis and cellular rejuvenation

• KPV: Alpha-MSH fragment researched for anti-inflammatory properties

• BPC-157: Peptide studied in tissue regeneration and inflammation models

• TB500: Thymosin beta-4 analog investigated for cell migration and angiogenesis

• Sterile vial format supports reproducible and stable peptide combination studies

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.